Plain-English translation of NCT06782490 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help reduce muscle stiffness (spasticity) that happens with multiple sclerosis. Researchers want to find out if the medication works, how safe it is, and how well people tolerate it. You would receive one of three different doses of the medication or a placebo (a dummy pill with no active ingredient).
Muscle stiffness is a common and bothersome symptom for many people with multiple sclerosis, and current treatment options don't work well for everyone. This trial is exploring whether this new treatment might offer better relief for patients who need it.
You likely qualify if…
You likely don't qualify if…
You would visit the study site for regular appointments where you would take a daily pill — either the new medication at one of three dose levels or a placebo. The study is double-blind, meaning neither you nor the researchers will know which treatment you're receiving. Researchers will assess your muscle stiffness and ask about any side effects you experience throughout the study to determine whether the medication is working and is safe.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States